Skip Navigation

Cardiovascular Research 2007 75(1):148-157; doi:10.1016/j.cardiores.2007.04.011
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Palanivel, R.
Right arrow Articles by Sweeney, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palanivel, R.
Right arrow Articles by Sweeney, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes

Rengasamy Palanivela, Xiangping Fanga, Min Parka, Megumi Eguchia, Shelley Pallana, Sabrina De Girolamoa, Ying Liua, Yu Wangb, Aimin Xuc and Gary Sweeneya,*

aDepartment of Biology, York University, Toronto, Ontario, Canada M3J 1P3
bGenome Research Center, University of Hong Kong, China
cDepartment of Medicine, University of Hong Kong, China

* Corresponding author. Tel: +1 416 736 2100x66635; fax: +1 416 736 5698. gsweeney{at}yorku.ca

Objective Our aim was to investigate the regulation of glucose and fatty acid metabolism in cardiomyocytes by the globular (gAd) and full-length (fAd) forms of adiponectin.

Methods We produced fAd (consisting of high, medium and low molecular weight oligomers) in a mammalian expression system and gAd in bacteria. These were used to treat primary neonatal rat cardiomyocytes (up to 48 h), and we employed 3H- or 14C-labeled substrates to monitor glucose uptake and subsequent metabolism via oxidation, glycogen synthesis or lactate production and fatty acid uptake and oxidation. Enzymatic assay for acetyl CoA carboxylase activity was employed, and protein phosphorylation and expression was determined by immunoblotting cell lysates. The role of adiponectin receptor (AdipoR) isoforms was determined via siRNA-mediated knockdown.

Results There was an initial (1 h) increase in glucose uptake and oxidation in response to gAd or fAd. Fatty acid uptake was stimulated by gAd or fAd, and by 24 h a decrease in acetyl CoA carboxylase activity and elevated fatty acid oxidation were observed. After 48 h increased fatty acid oxidation correlated with decreased glucose oxidation and pyruvate dehydrogenase activity, while glycogen synthesis and lactate production increased. Both gAd and fAd elicited phosphorylation of AMP kinase, insulin receptor substrate-1, Akt and glycogen synthase kinase-3β. Knockdown of AdipoR1 or AdipoR2 attenuated the effect of both gAd and fAd on fatty acid uptake and oxidation. Only AdipoR1 knockdown prevented the ability of gAd (1 h) to increase glucose uptake and oxidation; however, reducing either AdipoR1 or AdipoR2 expression attenuated the long-term (24 h) effects of gAd.

Conclusions These results clearly demonstrate that gAd and fAd mediate distinct and time-dependent effects on cardiomyocyte energy metabolism via AdipoR1 and AdipoR2.

KEYWORDS Adiponectin; Obesity; Diabetes; Glucose and fatty acid uptake and metabolism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley
Myocardial Fatty Acid Metabolism in Health and Disease
Physiol Rev, January 1, 2010; 90(1): 207 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Iozzo, R. Lautamaki, R. Borra, H.-R. Lehto, M. Bucci, A. Viljanen, J. Parkka, V. Lepomaki, R. Maggio, R. Parkkola, et al.
Contribution of Glucose Tolerance and Gender to Cardiac Adiposity
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4472 - 4482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-Y. Park, J. H. Choi, H. S. Ryu, Y. K. Pak, K. S. Park, H. K. Lee, and W. Lee
C1q Tumor Necrosis Factor {alpha}-related Protein Isoform 5 Is Increased in Mitochondrial DNA-depleted Myocytes and Activates AMP-activated Protein Kinase
J. Biol. Chem., October 9, 2009; 284(41): 27780 - 27789.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R. Palanivel, V. Vu, M. Park, X. Fang, and G. Sweeney
Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes
J. Endocrinol., December 1, 2008; 199(3): 389 - 397.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. D. Abel, S. E. Litwin, and G. Sweeney
Cardiac Remodeling in Obesity
Physiol Rev, April 1, 2008; 88(2): 389 - 419.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
A. H Barnett
The importance of treating cardiometabolic risk factors in patients with type 2 diabetes
Diabetes and Vascular Disease Research, March 1, 2008; 5(1): 9 - 14.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Saito, D. Fujioka, K.-i. Kawabata, T. Kobayashi, T. Yano, T. Nakamura, Y. Kodama, H. Takano, Y. Kitta, J.-e. Obata, et al.
Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-{alpha}-treated cardiomyocytes in association with improved glucose uptake
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3490 - H3497.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.